AAIC 2025 Abstract·11 JanLarge‐scale cerebrospinal fluid proteomics identifies molecular signatures of disease progression across Alzheimer's disease and sporadic frontotemporal lobar degenerationStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·26 DecClinical associations of CSF TMEM106B in familial and sporadic frontotemporal lobar degenerationStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecTargeted proteomics via NULISAseq identifies blood‐detectable markers of disease progression in familial frontotemporal lobar degenerationStudy in peopleBiomarkersPaper